These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 8953683

  • 1. Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group.
    Brismar B, Akerlund JE, Sjöstedt S, Johansson C, Törnqvist A, Bäckstrand B, Bång H, Andåker L, Gustafsson PO, Darle N, Angerås M, Falk A, Tunevall G, Kasholm-Tengve B, Skau T, Nyström PO, Gasslander T, Hagelbäck A, Olsson-Liljequist B, Eklund AE, Nord CE.
    Scand J Infect Dis; 1996; 28(5):507-12. PubMed ID: 8953683
    [Abstract] [Full Text] [Related]

  • 2. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Brismar B, Malmborg AS, Tunevall G, Lindgren V, Bergman L, Mentzing LO, Nyström PO, Anséhn S, Bäckstrand B, Skau T.
    J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761
    [Abstract] [Full Text] [Related]

  • 3. A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections.
    Angerås MH, Darle N, Hamnström K, Ekelund M, Engström L, Takala J, Viste A, Holme JB.
    Scand J Infect Dis; 1996 Jan; 28(5):513-8. PubMed ID: 8953684
    [Abstract] [Full Text] [Related]

  • 4. Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: results of a prospective, randomized, multicentre trial.
    Basoli A, Meli EZ, Mazzocchi P, Speranza V.
    Scand J Infect Dis; 1997 Jan; 29(5):503-8. PubMed ID: 9435041
    [Abstract] [Full Text] [Related]

  • 5. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
    Colardyn F, Faulkner KL.
    J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
    [Abstract] [Full Text] [Related]

  • 6. A multicenter, randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infections.
    Jia B, Lu P, Huang W, Li C, Huang A, Zhou X, Zhang W, Wu G, Zhang G.
    Chemotherapy; 2010 Sep; 56(4):285-90. PubMed ID: 20714145
    [Abstract] [Full Text] [Related]

  • 7. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
    Brismar B, Malmborg AS, Tunevall G, Wretlind B, Bergman L, Mentzing LO, Nyström PO, Kihlström E, Bäckstrand B, Skau T.
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2766-73. PubMed ID: 1336347
    [Abstract] [Full Text] [Related]

  • 8. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
    Eklund AE, Nord CE.
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():79-85. PubMed ID: 8383657
    [Abstract] [Full Text] [Related]

  • 9. [Meropenem (Merrem) vs imipenem/cilastatin in hospital treatment of intra-abdominal infections. A multicenter study].
    Tonelli F.
    Minerva Chir; 1997 Mar; 52(3):317-26. PubMed ID: 9148225
    [Abstract] [Full Text] [Related]

  • 10. A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients.
    Cox CE, Holloway WJ, Geckler RW.
    Clin Infect Dis; 1995 Jul; 21(1):86-92. PubMed ID: 7578765
    [Abstract] [Full Text] [Related]

  • 11. Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group.
    Donahue PE, Smith DL, Yellin AE, Mintz SJ, Bur F, Luke DR.
    Am J Surg; 1998 Dec; 176(6A Suppl):53S-61S. PubMed ID: 9935258
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of obstetric and gynecologic infections with meropenem: comparison with imipenem/cilastatin.
    Maggioni P, Di Stefano F, Facchini V, Irato S, Mancuso S, Colombo M, Massobrio M, Melis GB, Crosignani P.
    J Chemother; 1998 Apr; 10(2):114-21. PubMed ID: 9603636
    [Abstract] [Full Text] [Related]

  • 14. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
    de Groot HG, Hustinx PA, Lampe AS, Oosterwijk WM.
    J Antimicrob Chemother; 1993 Sep; 32(3):491-500. PubMed ID: 8262872
    [Abstract] [Full Text] [Related]

  • 15. Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. Meropenem Study Group.
    Geroulanos SJ.
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():191-205. PubMed ID: 8543495
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections.
    Garau J, Blanquer J, Cobo L, Corcia S, Daguerre M, de Latorre FJ, León C, Del Nogal F, Net A, Rello J.
    Eur J Clin Microbiol Infect Dis; 1997 Nov; 16(11):789-96. PubMed ID: 9447899
    [Abstract] [Full Text] [Related]

  • 18. Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.
    Walters DJ, Solomkin JS, Paladino JA.
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):551-61. PubMed ID: 10662480
    [Abstract] [Full Text] [Related]

  • 19. Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection.
    Dietrich ES, Schubert B, Ebner W, Daschner F.
    Pharmacoeconomics; 2001 Jan; 19(1):79-94. PubMed ID: 11252548
    [Abstract] [Full Text] [Related]

  • 20. A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus.
    Embil JM, Soto NE, Melnick DA.
    Clin Ther; 2006 Aug; 28(8):1164-1174. PubMed ID: 16982293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.